Background Cellulitis is a commonly encountered bacterial infection among cirrhotic patients apart from spontaneous bacterial peritonitis, urinary tract and respiratory infections. Th is study aimed to determine the risk factors of cellulitis in cirrhosis and whether antibiotic prophylaxis helps prevent recurrence of cellulitis.
Introduction
Cirrhotic patients are more prone to serious bacterial infections [1] . Th ese infections precipitate decompensation of cirrhosis and thus lead to increased morbidity and mortality [2] . Th e increased infections in cirrhotic patients are due to the defect in the immune system which includes both humoral and cellular immunity [3] [4] [5] [6] . Cellulitis is one of the major bacterial infections seen in cirrhosis apart from spontaneous bacterial peritonitis (SBP), urinary and respiratory tract infections. Th e prevalence of cellulitis in cirrhosis is 10.5-12.5% [7, 8] . A nationwide population based study in Taiwan has shown that cirrhotic patients are at increased risk of cellulitis than non-cirrhotics [6] .
Cellulitis in cirrhotic patients is diff erent from that of the general population regarding microorganisms, pathogenesis and prognosis. Bacterial translocation (BT) from gut is postulated to be a major source of infections in cirrhosis [9] . As opposed to cellulitis in the general population, where the major etiological organisms are gram positive bacteria (Group A streptococci and Staphylococcus aureus) [10, 11] cellulitis due to gram negative organisms are frequently reported in cirrhotic patients [12, 13] . Th is suggests that, as in the case of SBP [3] , BT from the gut may play a major role in pathogenesis of cellulitis in cirrhosis. Norfl oxacin prophylaxis has helped reduce the one-year probability of developing SBP from 61% to 7% [14] and recurrence of SBP decreased from 68 to 20% [15] . We hypothesize that in cirrhotic patients with cellulitis antibiotic prophylaxis might help prevent the recurrence of cellulitis. Th e present study aimed to identify the risk factors of cellulitis in cirrhosis and to assess the role of antibiotic prophylaxis in preventing the recurrence of cellulitis.
Patients and methods

Study design and setting
Th e study was conducted in two phases (Phase 1 and Phase 2), in the Medical Gastroenterology department of a tertiary care hospital in South India. Phase 1 was a case control study to identify the risk factors of cellulitis in cirrhosis. Consecutive patients admitted with cirrhosis and cellulitis (n=70), between August 2011 and August 2013 were included as cases. Controls were age-and sex-matched cirrhotic patients without cellulitis or without past history of cellulitis, selected from the same center (n=73). Patients with a history of signifi cant trauma and known cases of fi lariasis were excluded. Cellulitis was diagnosed by the presence of erythema, warmth and swelling of the aff ected area [16] . Doppler ultrasound was used to exclude deep vein thrombosis in suspicious cases.
Phase 2 was a cohort study to look for the role of antibiotics in preventing recurrence of cellulitis in cirrhosis. Of the 70 cases with cellulitis in phase 1, fi ve died during admission, four were lost to follow up, and the rest of the 61 cases were included in phase 2.
Method of patient evaluation
In phase 1, data regarding age, sex, etiology of cirrhosis, comorbidities, duration of liver disease, site of cellulitis, ChildTurcotte-Pugh (CTP) score, model for end-stage liver disease (MELD) score, presence of edema, ascites, SBP, hepatorenal syndrome (HRS), acute kidney injury (AKI), alcoholic hepatitis (AH), hepatic encephalopathy (HE), hemoglobin (Hb) level, platelet count, erythrocyte sedimentation rate, international normalized ratio, serum creatinine, bilirubin, albumin, and sodium levels were collected and compared with those of controls. Report of blood culture or culture from the infected skin was also noted.
In phase 2, two cohorts were identifi ed from cellulitis cases of phase 1 based on the initiation of antibiotic (norfl oxacin or rifaximin) at the time of discharge (as primary or secondary prophylaxis for SBP, or for HE). Th ose who were initiated on antibiotic prophylaxis were assigned to group 1 and those who were not initiated on antibiotic prophylaxis were assigned to group 2. Both groups were followed up and data regarding recurrence of cellulitis within six months were collected. We compared the recurrence of cellulitis between the two groups.
Th e study was approved by the institutional ethics committee and the hospital review board.
Statistical analysis
Continuous variables were described by mean ± SD; categorical variables were described by percentages. Association between study variables were assessed by t-test, Chi square test and Mann Whitney U test depending upon the nature of study variables. Th e logistic regression was done to identify the risk factors. Odds ratio (OR) and confi dence interval (CI) were calculated. Relative Risk and number needed to treat (NNT) were calculated to assess the eff ect of antibiotic prophylaxis. Statistical analysis was done using SPSS ver. 17.
Results
Th ere were 70 patients with cellulitis (cases) and 73 patients without cellulitis (controls). Univariate analysis of various parameters of cases and controls is shown in Tables 1 and 2 . Among the cases, 61 (87%) were males and 9 (13%) were females. Mean age was 51.7 years. Etiology of cirrhosis were alcoholic liver disease in 47 (67%) patients, nonalcoholic steatohepatitis in 9 (12.8%), chronic hepatitis B in 8 (11.4%), chronic hepatitis C in 5 (7.1%), and Wilson disease in 1 (1.4%). Forty eight (68%) were Child C, 20 (29%) were Child B and 2 (3%) were Child A. Mean duration between diagnosis of cirrhosis and development of cellulitis was 19.3 months. Twenty seven (39%) were diabetics. Ascites was present in 54 (77%) and SBP was present in 25 (36%). Twenty one cases (30%) had HE, 14 (22%) had AKI, 14 (22%) had AH, 6 (8.6%) had hepatocellular carcinoma, and 5 (4%) developed HRS. Fift y four patients had edema of lower limbs, and 7 had scrotal edema. Sixty cases (85%) presented with cellulitis of lower limbs, 9 (13%) had scrotal cellulitis, and one had anterior abdominal wall cellulitis. Culture was positive in 31% (22/70) either from blood or from skin aspirates (10 from blood, 9 from skin, and 3 from both). 73% of culture (16/22) showed growth of gram negative organisms. Th e organisms were Klebsiella pneumoniae in 6 (27%) patients, Pseudomonas aeruginosa in 6 (27%) and Escherichia coli in 4 (18%) cases. Twenty seven percent (6/22) had Staphylococcus aureus of which two were methicillinresistant Staphylococcus aureus (MRSA). Out of 45 cellulitis patients without SBP, 10 had culture positivity of which 8 were gram negative organisms (2 Pseudomonas, 4 Klebsiella, 2 E. coli) and 2 were gram positive (Staphylococcus). Of the 9 cellulitis cases where the skin culture was positive, 8 cases showed growth of gram negative organisms.
Treatment
Th e patients were initially treated with intravenous cefotaxime. Nineteen patients (27%) were switched over to piperacillin-tazobactam due to poor response to cefotaxime. Ceft azidime was initiated for one patient with Pseudomonas infection, linezolid was given to patients with MRSA and cefoperazone for 2 patients with Klebsiella infection as per culture and sensitivity. Th ere was a signifi cant diff erence in the mean number of days of hospitalization, among cases (6.4 days) and controls (5 days) P=013.
Risk factors of cellulitis
On univariate analysis, presence of diabetes, HE, platelet count, serum albumin level, and MELD score showed a signifi cant diff erence between cases and controls. On logistic regression (Table 3) , HE (P=0.048, OR 2.925, C.I 1.012-8.458), albumin <2.5 g/dL (P=0.007, OR 2.804, CI 1.328-5.922), and MELD score >15 (P=0.005, OR 2.958, CI 1.395-6.27) showed signifi cant diff erences between the two groups.
Recurrence and mortality
On follow up in phase 2, out of 61 cellulitis cases, 12 (20%) had recurrence of cellulitis within 6 months. Of these, 51 were in group 1 (those patients who were started on antibiotic prophylaxis at the time of discharge) and 10 patients were in group 2 (discharged without antibiotic prophylaxis). Th e recurrence rate in group 1 was 14% (7/51) whereas in group 2 it was 50% (5/10) which was statistically signifi cant (P=0.048), with a relative risk of 0.27 and the NNT was 3. Table 4 shows baseline characteristics of group 1 and group 2. In univariate analysis none of the other variables showed a signifi cant diff erence between these two groups. Logistic regression showed that antibiotic prophylaxis signifi cantly reduced the recurrence of cellulitis (P=0.011, OR 0.099, CI 0.017-0.583) ( Table 5) .
Mortality of the follow up cases of cellulitis (n=61) was at 1 month 15.7%, at 3 months 27.1% and at 6 months 32.8%. Of the 23 patients who expired during the follow up period, 18 belonged to the antibiotic prophylaxis group (18/51, 35%), while 5 belonged to the no-prophylaxis group (5/10, 50%). Th e causes of death were sepsis in 9 (5 related to cellulitis, and 4 unrelated to cellulitis), uncontrolled upper GI bleeding in 6, severe alcoholic hepatitis in 4, HCC in 3, and HRS in 1.
Discussion
To date, there are only very few studies in the literature conducted to assess the risk factors of cellulitis in cirrhotic patients. In this hospital-based case-control study we found that hypoalbuminemia, high MELD score, and HE are the factors signifi cantly associated with cellulitis in cirrhotic patients. In our study, MELD score >15 (OR 2.95, CI 1.39-6.27) was observed as a signifi cant risk factor for cellulitis. Poor liver function results in increased susceptibility to infection due to immune system defects, including the defective bactericidal function of immunoglobulin, decreased polymorphonuclear leukocyte activity, complement defi ciency, and reduced number of Kupff er cells [17] . Th e majority of cellulitis patients (68%) belonged to Child C status. Gut BT is found to be signifi cantly increased in Child C than in Child A and B patients [9] . However, our study did not show Child to be a signifi cant variable. Th is could be due to the fact that the control group were selected from the patients who were admitted with complications of cirrhosis (other than cellulitis), which might have refl ected as high CTP score in the control group.
Our data showed that low serum albumin (<2.5 g/dL, OR 2.80, CI 1.32-5.92) is signifi cantly associated with the development of cellulitis. Th is fi nding is comparable with the observation in another south Indian study [7] . Th is fi nding also points to the fact that poor functional status of the liver is the predisposing factor for cellulitis in cirrhosis. Other studies have shown that in cellulitis patients, hypoalbuminemia is signifi cantly associated with mortality in cirrhotic patients as well as the general population [18, 19] .
In our study, HE was signifi cantly associated with cellulitis in cirrhotic patients (OR 2.95, CI 1.01-8.45). Th is association of HE with cellulitis could be either a cause or an eff ect. Cellulitis may be the predisposing factor for HE. Bacterial translocation is considered to be important in the pathogenesis of both HE [20] and cellulitis [21] . Th e gut mucosa of cirrhotic patients is more permeable to bacteria than normal mucosa [22] . Portal systemic shunt circulation in cirrhotic patients will help the organism that gained access to the gastrointestinal tract to escape phagocytosis by hepatic reticuloendothelial system, thereby establishing systemic bacteremia [18] . Th is bacteremia may result either in primary septicemia or localized infections like cellulitis. Likewise, because of the hepatocyte dysfunction and portosystemic shunting there are increased circulating levels of ammonia, primarily produced in the colon, which is the major neurotoxin involved in HE. On the other hand, HE in cirrhotic patients may predispose them to minor injuries of the lower limbs, of which the patient may be unaware, or they may neglect it due to encephalopathy. Th ese injuries serve as an entry port of bacteria and subsequently develop cellulitis. Our patients had both cellulitis and HE on admission and we could not establish which event occurred fi rst.
In our study, 77% of cellulitis patients had ascites, and 36% had SBP. Th is shows that cellulitis can occur independently in patients with cirrhosis without ascites or SBP. Gram-positive bacteria are the predominant organism isolated from cellulitis patients of the general population. But gram-negative bacteria are the major organism involved in cellulitis of cirrhotic patients [7, 12, 13] . In our study, 73% of culture from blood or pus showed growth of gram-negative bacilli (Klebsiella, Pseudomonas and E. coli), and 27% showed growth of Staphylococcus. Th e predominance of gut fl ora in the cultures from cellulitis patients with cirrhosis is probably related to intestinal bacterial overgrowth and increased BT [23] . Th ough diabetes mellitus is a risk factor for cellulitis in the general population, surprisingly, our study did not fi nd diabetes as a risk factor in cirrhotic patients.
Th is is the fi rst study to assess the role of antibiotics in preventing recurrence of cellulitis in cirrhosis. On follow up 20% of cases had recurrence of cellulitis within 6 months which is comparable with 21.4% recurrence rate reported by Catherine et al [24] . Th e follow-up group showed decreased recurrence of cellulitis among patients who were started on antibiotic prophylaxis compared with those who were not on prophylaxis (15% vs. 50%, P=0.048). Th e NNT was 3. Logistic regression analysis showed that antibiotic prophylaxis independently reduced the rate of cellulitis recurrence. Th is novel fi nding suggests that the administration of prophylactic antibiotics in cirrhotic patients with cellulitis will help decrease the recurrence of cellulitis. However this should be analyzed in further larger prospective studies. Another hypothesis, we would like to suggest is that antibiotic prophylaxis may help prevent the development of cellulitis in at risk cirrhotic patients, with albumin <2.5 g/dL and MELD score >15.
Our study has certain strengths and limitations. Th is is the fi rst study to assess the role of antibiotics in preventing recurrence of cellulitis in cirrhosis and is one of the very few case control studies which looked into the risk factors of cellulitis in cirrhotic patients. Th e study has demonstrated the novel fi nding that antibiotic prophylaxis is useful in preventing recurrence of cellulitis. Th is fi nding has important clinical implications, because it may help to reduce repeated hospital admissions in these patients. Th e limitation of the study is that as the data are collected from inpatients of a tertiary care center, the sample may not exactly represent the general population of cirrhotic patients. Th e number of patients in group 2 in the follow-up phase was lower. Since most of the patient had indication for initiation of SBP prophylaxis (primary or secondary prophylaxis) based on AASLD recommendations, we were bound to start antibiotics. Also many patients had HE, for which antibiotics were needed. Th us patients in the non prophylactic group became less in number. Even though the number is small, the statistical signifi cance suggests that the association is relevant. Another limitation of our study is that we could not retrieve the data regarding antibiotic exposure prior to development of cellulitis.
In conclusion, our study demonstrated that hypoalbuminemia and high MELD score are the risk factors for cellulitis in cirrhosis. Antibiotic prophylaxis in cirrhotic patients with cellulitis will help prevent recurrence of cellulitis. Th is also points to the need for further studies which will guide for primary or secondary antibiotic prophylaxis for cellulitis in cirrhotic patients who have high-risk factors.
